Cargando…

Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study

Detalles Bibliográficos
Autores principales: Montillo, M, O'Brien, S, Tedeschi, A, Byrd, J C, Dearden, C, Gill, D, Brown, J R, Barrientos, J C, Mulligan, S P, Furman, R R, Cymbalista, F, Plascencia, C, Chang, S, Hsu, E, James, D F, Hillmen, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386339/
https://www.ncbi.nlm.nih.gov/pubmed/28157216
http://dx.doi.org/10.1038/bcj.2017.5
_version_ 1782520749864517632
author Montillo, M
O'Brien, S
Tedeschi, A
Byrd, J C
Dearden, C
Gill, D
Brown, J R
Barrientos, J C
Mulligan, S P
Furman, R R
Cymbalista, F
Plascencia, C
Chang, S
Hsu, E
James, D F
Hillmen, P
author_facet Montillo, M
O'Brien, S
Tedeschi, A
Byrd, J C
Dearden, C
Gill, D
Brown, J R
Barrientos, J C
Mulligan, S P
Furman, R R
Cymbalista, F
Plascencia, C
Chang, S
Hsu, E
James, D F
Hillmen, P
author_sort Montillo, M
collection PubMed
description
format Online
Article
Text
id pubmed-5386339
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-53863392017-04-26 Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study Montillo, M O'Brien, S Tedeschi, A Byrd, J C Dearden, C Gill, D Brown, J R Barrientos, J C Mulligan, S P Furman, R R Cymbalista, F Plascencia, C Chang, S Hsu, E James, D F Hillmen, P Blood Cancer J Letter to the Editor Nature Publishing Group 2017-02 2017-02-03 /pmc/articles/PMC5386339/ /pubmed/28157216 http://dx.doi.org/10.1038/bcj.2017.5 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Montillo, M
O'Brien, S
Tedeschi, A
Byrd, J C
Dearden, C
Gill, D
Brown, J R
Barrientos, J C
Mulligan, S P
Furman, R R
Cymbalista, F
Plascencia, C
Chang, S
Hsu, E
James, D F
Hillmen, P
Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study
title Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study
title_full Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study
title_fullStr Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study
title_full_unstemmed Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study
title_short Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study
title_sort ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the resonate study
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386339/
https://www.ncbi.nlm.nih.gov/pubmed/28157216
http://dx.doi.org/10.1038/bcj.2017.5
work_keys_str_mv AT montillom ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy
AT obriens ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy
AT tedeschia ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy
AT byrdjc ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy
AT deardenc ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy
AT gilld ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy
AT brownjr ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy
AT barrientosjc ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy
AT mulligansp ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy
AT furmanrr ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy
AT cymbalistaf ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy
AT plascenciac ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy
AT changs ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy
AT hsue ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy
AT jamesdf ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy
AT hillmenp ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy